PLX
Protalix Biotherapeutics
Description:
Protalix Biotherapeutics Inc. is a biopharmaceutical company based in Karmiel, Israel, specializing in the development and commercialization of recombinant therapeutic proteins using its proprietary ProCellEx plant cell-based expression system. The company aims to meet unmet medical needs with a promising pipeline targeting various conditions, with particular focus on emerging markets such as Israel, Brazil, and Latin America. With a robust commitment to innovation and strategic international growth, Protalix positions itself as an influential player in the biotechnology sector, presenting substantial opportunities for improved patient outcomes and value creation for institutional investors.
Address:
2 UNIVERSITY PLAZA, HACKENSACK, NJ, UNITED STATES, 07601
Fiscal year end:
December
Market capitalization:
$151 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-77%
How much will you get:
$228
Prices dates:
30-10-2015: $10.40 and 31-10-2025: $2.37